Stocks Comparison
Alpha Teknova vs Trinity Biotech: revenue, profit, margins and growth compared
Alpha Teknova brought in $40.5M of revenue in fiscal 2025, Trinity Biotech $61.6M in fiscal 2024. Revenue changed by +7.4% at Alpha Teknova and +8.3% at Trinity Biotech on the year before, so Trinity Biotech grew faster. Alpha Teknova kept -42.6% of its revenue as net profit, Trinity Biotech -51.6%. Free cash flow was -$9.8M at Alpha Teknova and -$4.6M at Trinity Biotech.
Side by side, latest fiscal year
| TKNO | TRIB | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2024 (December 31, 2024) |
| Revenue | $40.5M | $61.6M |
| Revenue growth | +7.4% | +8.3% |
| Net income | -$17.3M | -$31.8M |
| Net margin | -42.6% | -51.6% |
| Free cash flow | -$9.8M | -$4.6M |
| Free cash flow margin | -24.2% | -7.5% |
| Earnings per share (diluted) | -$0.32 | n/a |
| Cash | $5.9M | $5.2M |
| Debt | $13.1M | n/a |
| Price to earnings | n/a | n/a |
| Market value | $500.9M | n/a |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #391 of 646 · Health care | #358 of 646 · Health care |
Over the years
Questions about Alpha Teknova and Trinity Biotech
Which is bigger by revenue, Alpha Teknova or Trinity Biotech?
Trinity Biotech is bigger by revenue: $61.6M in fiscal 2024, against $40.5M for Alpha Teknova in fiscal 2025.
Which keeps more of its revenue as profit, Alpha Teknova or Trinity Biotech?
Alpha Teknova had a net margin of -42.6% in fiscal 2025; Trinity Biotech had -51.6% in fiscal 2024.
Which grew revenue faster, Alpha Teknova or Trinity Biotech?
In their latest fiscal years revenue changed by +7.4% at Alpha Teknova and +8.3% at Trinity Biotech.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.